排序方式: 共有35条查询结果,搜索用时 31 毫秒
1.
E. SCOTT SILLS IRENA KIRMAN LILIANA T. COLOMBERO JUNE HARIPRASHAD ZEV ROSENWAKS GIANPIERO D. PALERMO 《American journal of reproductive immunology (New York, N.Y. : 1989)》1998,40(1):43-47
PROBLEM: Restricted expression of H-Y antigen on Y-chromosome-bearing sperm has been reported in some species, although such preferential expression for H-Y antigen in human sperm has yet to be described. In this study, an immunomagnetic approach was used to characterize antigen expression patterns as a function of sex-chromosome content. METHOD OF STUDY: Human sperm was treated with monoclonal immunoglobulin (Ig) M antibodies directed against H-Y antigen. This preparation then was incubated with sheep antimouse IgM antibody affixed to paramagnetic beads, which then were exposed to a magnetic field and sorted. X- and Y-chromosome frequencies in the two subgroups of sperm were assayed by multiprobe fluorescent in situ hybridization (FISH). RESULTS: Sperm were immunomagnetically separated into two populations: a reactive group (presumably, H-Y Ag+); and a nonreactive group (presumably, H-Y Ag-). Triple-color FISH analysis of 1,600 spermatozoa (800 in each group) showed the antigen's expression to be somewhat more prevalent among Y-chromosome-bearing sperm (54.1%), but a large proportion of Y-chromosome-bearing sperm (49.0%) did not express this antigen. The difference was not significant (P = 0.43). CONCLUSIONS: The expression of H-Y antigen has a slightly higher frequency in human sperm containing the Y-chromosome, but its expression among X-chromosome-bearing sperm also is considerable. Current immunologic techniques relying on this antigen are unlikely to effect the sex selection of human sperm. 相似文献
2.
3.
4.
5.
J.M. GARCÍA PRIM
md phd F.J. GONZÁLEZ BARCALA
md phd J. PAZ ESQUETE
md A. POSE REINO
md phd A. FONDEVILA LÓPEZ
md L. VALDÉS CUADRADO
md phd 《European journal of cancer care》2010,19(2):227-233
GARCÍA PRIM J.M., GONZÁLEZ BARCALA F.J., PAZ ESQUEJE J., POSE REINO A., FONDEVILA LÓPEZ A. & VALDÉS CUADRADO L. (2010) European Journal of Cancer Care 19 , 227–233 Lung cancer in a health area of Spain: incidence, characteristics and survival To examine the incidence, characteristics, therapeutic approach and survival of diagnosed lung cancer (LC) in the Santiago de Compostela Health Area. A retrospective study was carried out on LC for a period of 3 years. Of the 481 cases collected, 92.7% were male. The median age was 66.93 years. The crude incidence for men and women was 80.71 and 5.84 per 100 000 inhabitants respectively. Among the non‐small cell lung cancers (NSCLC), 68.1% were diagnosed in stage IIIB or IV. The cancer had already spread in 62.2% of the small cell lung cancer (SCLC). Chemotherapy was used in 51.6% of patients. The survival probability from the first to the fifth year was 47.7%, 24.3%, 12.9%, 10% and 8.9% respectively. The median survival at 5 years was 12.12 months for NSCLC, rising to 29.8 months in stage I, and 8.85 months in SCLC. In our Health Area LC occurs more often in men, in whom the prevalence of smoking is very high. The most common histology type was squamous cell carcinoma. In the majority of cases, the diagnosis is made in the advanced stages, which accounts for the low percentage of surgical treatments and the short survival. 相似文献
6.
ESTEBAN GONZÁLEZ‐TORRECILLA M.D. Ph.D. ÁNGEL ARENAL MAÍZ M.D. Ph.D. PABLO ÁVILA ALONSO M.D. FRANCISCO FERNÁNDEZ‐AVILÉS M.D. Ph.D. 《Pacing and clinical electrophysiology : PACE》2017,40(1):63-66
A 75‐year‐old man was admitted due to an electrical storm with appropriate recurrent implantable cardioverter defibrillator (ICD) discharges. The patient had had an extensive anterolateral myocardial infarction with associated severe left ventricular dysfunction 10 years earlier (left ventricular ejection fraction, 25%), and an ICD was placed 9 years before admission for primary prevention of sudden cardiac death. A first invasive study induced up to five ventricular tachycardias and an extensive endocardial substrate ablation was performed. Despite intravenous β‐blockers, general anesthesia and procainamide infusion, the patient continued to have recurrent episodes of very slow sustained ventricular tachycardia with a right bundle branch block pattern. In a subsequent invasive study, no mid‐diastolic activity was found despite careful mapping during the induced clinical ventricular tachycardia and ablation attempts inside the apical endocardial scar were unsuccessful. A percutaneous epicardial approach with navigation system support (EnSite PrecisionTM Cardiac Mapping System v. 2.0, St. Jude Medical, St. Paul, MN, USA) without antiarrhythmic infusion was planned. A wide QRS complex rhythm with alternating QRS morphology was readily induced by epicardial ventricular pacing trains (Fig. 1, top) that elicited both arrhythmia QRS patterns with very long stimulus QRS intervals (Fig. 1, bottom). What is the possible mechanism of this arrhythmia? Do we need further pacing maneuvers during the arrhythmia to localize critical sites at which ablation pulses can predictably be successful? 相似文献
7.
FELIPE BISBAL M.D. Ph.D. FEDERICO GÓMEZ‐PULIDO M.D. PILAR CABANAS‐GRANDÍO M.D. Ph.D. NAZEM AKOUM M.D. MIREIA CALVO M.eng. DAVID ANDREU B.eng. Ph.D. SUSANNA PRAT‐GONZÁLEZ M.D. Ph.D. ROSARIO J. PEREA M.D. Ph.D. ROGER VILLUENDAS M.D. ANTONIO BERRUEZO M.D. Ph.D. MARTA SITGES M.D. Ph.D. ANTONI BAYÉS‐GENÍS M.D. Ph.D. JOSEP BRUGADA M.D. Ph.D. NASSIR F. MARROUCHE M.D. LLUÍS MONT M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2016,27(7):804-810
8.
T. SOBRINO M. MILLÁN M. CASTELLANOS M. BLANCO D. BREA L. DORADO R. RODRÍGUEZ‐GONZÁLEZ M. RODRÍGUEZ‐YÁÑEZ J. SERENA R. LEIRA A. DÁVALOS J. CASTILLO 《Journal of thrombosis and haemostasis》2010,8(7):1567-1574
Summary. Background: Growth factors (GF) such as vascular endothelial growth factor (VEGF), angiopoietin‐1 (Ang‐1) and granulocyte‐colony stimulating factor (G‐CSF) have been associated with greater efficacy of tissue plasminogen activator (tPA) in experimental studies. Objectives: To study the association of these GF with arterial recanalization and clinical outcome in patients with acute ischemic stroke treated with tPA. Methods: We prospectively studied 79 patients with ischemic stroke attributable to MCA occlusion treated with i.v. tPA within the first 3 h from onset of symptoms. Continuous transcranial color‐coded sonography (TCCS) was performed during the first 2 h after tPA bolus to assess early MCA recanalization. Hemorrhagic transformation (HT) was classified according to ECASS II definitions. Good functional outcome was defined as a Rankin scale score of 0–2 at 90 days. GF levels were determined by ELISA. Results: Mean serum levels of VEGF, G‐CSF and Ang‐1 at baseline were significantly higher in patients with early MCA recanalization (n = 30) (all P < 0.0001). In the multivariate analysis, serum levels of VEGF (OR, 1.03), G‐CSF (OR, 1.02) and Ang‐1 (OR, 1.07) were independently associated with early MCA recanalization (all P < 0.0001). On the other hand, patients with parenchymal hematoma (PH) (n = 20) showed higher levels of Ang‐1 (P < 0.0001). Ang‐1 (OR, 1.12; P < 0.0001) was independently associated with PH, whereas patients with good outcome (n = 38) had higher levels of G‐CSF (P < 0.0001). G‐CSF was independently associated with good outcome (OR, 1.12; P = 0.036). Conclusions: These findings suggest that GF may enhance arterial recanalization in patients with ischemic stroke treated with t‐PA, although they might increase the HT. 相似文献
9.
JOSÉ R. LÓPEZ‐MÍNGUEZ M.D. Ph.D. REYES GONZÁLEZ‐FERNÁNDEZ M.D. Ph.D. CONCEPCIÓN FERNÁNDEZ‐VEGAS B.Sc. VICTORIA MILLÁN‐NUÑEZ M.D. MARÍA E. FUENTES‐CAÑAMERO M.D. JUAN M. NOGALES‐ASENSIO M.D. Ph.D. JAVIER DONCEL‐VECINO M.D. JAVIER ELDUAYEN‐GRAGERA M.D. SIEW Y. HO Ph.D. F.R.C.Path DAMIÁN SÁNCHEZ‐QUINTANA M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2014,25(9):976-984
10.
JAVIER MORENO M.D. Ph.D. JORGE G. QUINTANILLA M.S.Eng. ROBERTO MOLINA‐MORÚA M.S.Eng. MARÍA JESÚS GARCÍA‐TORRENT Ph.D. MARÍA JOSÉ ANGULO‐HERNÁNDEZ B.S. CAROLINA CURIEL‐LLAMAZARES M.S.Eng. JULIO RAMIRO‐BARGUEÑO M.S.Eng. Ph.D. PABLO GONZÁLEZ V.M.D. ANTONIO J. CAAMAÑO M.S.Eng. Ph.D. NICASIO PÉREZ‐CASTELLANO M.D. Ph.D. JOSÉ LUIS ROJO‐ÁLVAREZ M.S.Eng. Ph.D. CARLOS MACAYA M.D. Ph.D. JULIÁN PÉREZ‐VILLACASTÍN M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2014,25(12):1391-1399